SCHEMBL3906444

SCHEMBL3906444

Clc1ccc(P(CCP(c2ccc(Cl)cc2)c2ccc(Cl)cc2)c2ccc(Cl)cc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.47
CYP2A6 P11509 1/20 0.47
IDO1 P14902 4/20 0.38
TAAR1 Q96RJ0 2/20 0.35
AGXT P21549 2/20 0.33
SLC6A4 P31645 1/20 0.33
CYP1A2 P05177 1/20 0.33
MIF P14174 1/20 0.33
TSHR P16473 1/20 0.33
GSK3B P49841 1/20 0.32
ALDH1A1 P00352 3/20 0.32
CES2 O00748 1/20 0.32
CES1 P23141 1/20 0.32
ENPP2 Q13822 1/20 0.32
CYP3A4 P08684 1/20 0.32
MAPK1 P28482 1/20 0.32
HSD17B10 Q99714 1/20 0.32
MEN1 O00255 1/20 0.31
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8966376 0.89 LMNA (0.42) LMNACYP2A6IDO1TAAR1AGXT
SCHEMBL8965957 0.89 LMNA (0.42) LMNACYP2A6IDO1TAAR1AGXT
SCHEMBL11600371 0.85 LMNA (0.38) LMNACYP2A6IDO1TAAR1SLC6A4
SCHEMBL9579902 0.81 SMN1; SMN2 (0.40) LMNACYP2A6GSK3BALDH1A1KDM4E
SCHEMBL11604805 0.78 LMNA (0.42) LMNACYP2A6IDO1TAAR1SLC6A4
SCHEMBL9788876 0.78 SMN1; SMN2 (0.42) ALDH1A1KDM4EL3MBTL1
SCHEMBL8966038 0.72 LMNA (0.36) LMNACYP2A6IDO1TAAR1SLC6A4
SCHEMBL8965573 0.72 SLC6A2 (0.39) LMNACYP2A6IDO1TAAR1SLC6A4
SCHEMBL8966334 0.72 SLC6A2 (0.39) LMNACYP2A6IDO1TAAR1SLC6A4
SCHEMBL152775 0.71 LMNA (0.57) LMNACYP2A6IDO1CYP1A2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1698609-B1 Process for producing an alcohol or its silyl ether TAKASAGO PERFUMERY CO LTD (JP) 2013-07-31 EP disclosed
US-7563916-B2 Process for producing an alcohol or a silyl ether thereof TAKASAGO INTERNATIONAL CORPORATION (JP) 2009-07-21 US disclosed
US-20060199973-A1 Process for producing an alcohol or a silyl ether thereof TAKASAGO INTERNATIONAL CORPORATION (JP) 2006-09-07 US disclosed
EP-1698609-A1 Process for producing an alcohol or its silyl ether Takasago International Corporation (JP) 2006-09-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060199973-A1 Process for producing an alcohol or a silyl ether thereof CBR1, RER1, ADH1A LMNA 2441/4885CYP2A6 1283/4885IDO1 3463/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.